202 related articles for article (PubMed ID: 37352112)
41. Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade.
Jacobs JEJ; L'Hoyes W; Lauwens L; Yu YL; Brusselmans M; Weltens C; Voigt JU; Wildiers H; Neven P; Herrmann J; Thijs L; Staessen JA; Janssens S; Van Aelst LNL
J Am Heart Assoc; 2023 Apr; 12(8):e027855. PubMed ID: 37026536
[TBL] [Abstract][Full Text] [Related]
42. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
43. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
44. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.
Jerusalem G; Lancellotti P; Kim SB
Breast Cancer Res Treat; 2019 Sep; 177(2):237-250. PubMed ID: 31165940
[TBL] [Abstract][Full Text] [Related]
45. Cancer in chronic heart failure patients in the GISSI-HF trial.
Ameri P; Canepa M; Luigi Nicolosi G; Marchioli R; Latini R; Tavazzi L; Maggioni AP;
Eur J Clin Invest; 2020 Sep; 50(9):e13273. PubMed ID: 32406516
[TBL] [Abstract][Full Text] [Related]
46. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
[TBL] [Abstract][Full Text] [Related]
47. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
Driscoll A; Currey J; Tonkin A; Krum H
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
[TBL] [Abstract][Full Text] [Related]
48. A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study.
Lidbrink E; Chmielowska E; Otremba B; Bouhlel A; Lauer S; Liste Hermoso M; Nüesch E; Shing M; Misra V
Breast Cancer Res Treat; 2019 Feb; 174(1):187-196. PubMed ID: 30506110
[TBL] [Abstract][Full Text] [Related]
49. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
[TBL] [Abstract][Full Text] [Related]
50. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
51. Direct oral anticoagulants in patients with hematologic malignancies.
Serrao A; Fiori L; Santoro C; De Luca ML; Ferretti A; De Luca G; Ligia S; Lapietra G; Mohamed S; Breccia M; Chistolini A
Hematol Oncol; 2020 Oct; 38(4):589-596. PubMed ID: 32588912
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
53. Cardiovascular mortality and morbidity burden in successive and age pre-stratified case-control cohorts of breast cancer women. A population-based study.
Staszewsky L; Robusto F; Lepore V; Bisceglia L; Petrarolo V; D'Ettorre A; Tognoni G; Latini R
Breast Cancer Res Treat; 2020 Aug; 183(1):177-188. PubMed ID: 32588164
[TBL] [Abstract][Full Text] [Related]
54. Risk-reducing medications for primary breast cancer: a network meta-analysis.
Mocellin S; Goodwin A; Pasquali S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883
[TBL] [Abstract][Full Text] [Related]
55. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
Narayan V; Ky B
Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
[TBL] [Abstract][Full Text] [Related]
56. Cardiovascular outcome of breast cancer patients with concomitant radiotherapy and chemotherapy: A 10-year multicenter cohort study.
Kim DY; Youn JC; Park MS; Lee S; Choi SW; Ryu KH; Kim LS; Shim MS; Lee JJ; Han S
J Cardiol; 2019 Aug; 74(2):175-181. PubMed ID: 30827728
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era.
Murphy AC; Koshy AN; Farouque O; Yeo B; Roccisano L; Octavia Y; Yudi MB
Heart Lung Circ; 2024 May; 33(5):648-656. PubMed ID: 37574416
[TBL] [Abstract][Full Text] [Related]
58. SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.
Lynce F; Barac A; Tan MT; Asch FM; Smith KL; Dang C; Isaacs C; Swain SM
Oncologist; 2017 May; 22(5):518-525. PubMed ID: 28314836
[TBL] [Abstract][Full Text] [Related]
59. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
60. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
